Amgen (AMGN)
NASDAQ:AMGN
Holding AMGN?
Track your performance easily

Amgen (AMGN) Financial Statements

5,913 Followers

Amgen Financial Overview

Amgen's market cap is currently ―. The company's EPS TTM is $5.804; its P/E ratio is 57.34; and it has a dividend yield of 2.67%. Amgen is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is $5.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 8.39B$ 7.45B$ 8.20B$ 6.90B$ 6.99B
Gross Profit$ 5.15B$ 4.25B$ 5.08B$ 6.90B$ 5.17B
EBIT$ 1.60B$ 861.00M$ -3.33B$ 7.71B$ 2.37B
EBITDA$ 3.00B$ 2.26B$ -1.95B$ 8.60B$ 3.26B
Net Income Common Stockholders$ 746.00M$ -113.00M$ 767.00M$ 1.73B$ 1.54B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.30B$ 9.71B$ 10.94B$ 34.70B$ 34.20B
Total Assets$ 90.91B$ 92.98B$ 97.15B$ 90.53B$ 90.22B
Total Debt$ 62.65B$ 64.02B$ 64.61B$ 60.47B$ 61.54B
Net Debt$ 53.34B$ 54.31B$ 53.67B$ 25.77B$ 27.34B
Total Liabilities$ 84.98B$ 87.96B$ 90.92B$ 82.88B$ 83.49B
Stockholders Equity$ 5.92B$ 5.02B$ 6.23B$ 7.66B$ 6.78B
Cash Flow-
Free Cash Flow$ 2.22B$ 459.00M$ 289.00M$ 2.51B$ 3.84B
Operating Cash Flow$ 2.46B$ 689.00M$ 538.00M$ 2.76B$ 4.11B
Investing Cash Flow$ -217.00M$ -217.00M$ -27.09B$ -262.00M$ -211.00M
Financing Cash Flow$ -2.65B$ -1.71B$ 2.75B$ -2.00B$ -1.21B
Currency in USD

Amgen Earnings and Revenue History

Amgen Debt to Assets

Amgen Cash Flow

Amgen Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis